Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Obesity drug trial halted: did cannabis compound fail to deliver?

NCT ID NCT04801641

First seen Apr 23, 2026 · Last updated May 22, 2026 · Updated 5 times

Summary

This study tested whether nabilone, a drug similar to cannabis, could help people with obesity lose weight safely. Researchers planned to enroll 18 obese adults and monitor weight, metabolism, and gut health. The trial was terminated early, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Center for Addiction and Mental Health

    Toronto, Ontario, M5S 2S1, Canada

Conditions

Explore the condition pages connected to this study.